Skip to main content
. 2008 Jan 2;2008:245410. doi: 10.1155/2008/245410

Figure 2.

Figure 2

An increase in renal tubulointerstitial area associated with streptozotocin diabetes in apoE KO mice is attenuated following treatment with PPARγ agonist, rosiglitazone, PPARα agonist, gemfibrozil, or the dual PPARα/γ agonist, ragaglitazar.